Literature DB >> 31849281

Personalized pediatric anesthesia and pain management: problem-based review.

Senthil Packiasabapathy1, Valluvan Rangasamy1, Nicole Horn1, Michele Hendrickson1, Janelle Renschler1, Senthilkumar Sadhasivam1.   

Abstract

Pharmacogenetics, the genetic influence on the interpersonal variability in drug response, has enabled tailored pharmacotherapy and emerging 'personalized medicine.' Although oncology spearheaded the clinical implementation of personalized medicine, other specialties are rapidly catching up. In anesthesia, classical examples of genetically mediated idiosyncratic reactions have been long known (e.g., malignant hyperthermia and prolonged apnea after succinylcholine). The last two decades have witnessed an expanding body of pharmacogenetic evidence in anesthesia. This review highlights some of the prominent pharmacogenetic associations studied in anesthesia and pain management, with special focus on pediatric anesthesia.

Entities:  

Keywords:  anesthesia; opioids; pain medicine; pediatric anesthesia; personalized medicine; pharmacogenetics

Mesh:

Substances:

Year:  2020        PMID: 31849281      PMCID: PMC7132778          DOI: 10.2217/pgs-2019-0108

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  155 in total

1.  Testing for malignant hyperthermia.

Authors:  Henry Rosenberg; Joseph F Antognini; Sheila Muldoon
Journal:  Anesthesiology       Date:  2002-01       Impact factor: 7.892

2.  Codeine, ultrarapid-metabolism genotype, and postoperative death.

Authors:  Catherine Ciszkowski; Parvaz Madadi; Michael S Phillips; Albert E Lauwers; Gideon Koren
Journal:  N Engl J Med       Date:  2009-08-20       Impact factor: 91.245

3.  A fatal case of malignant hyperthermia following isoflurane anaesthesia.

Authors:  A G Jensen; V Bach; M U Werner; H K Nielsen; M H Jensen
Journal:  Acta Anaesthesiol Scand       Date:  1986-05       Impact factor: 2.105

4.  Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli.

Authors:  Luda Diatchenko; Andrea G Nackley; Gary D Slade; Kanokporn Bhalang; Inna Belfer; Mitchell B Max; David Goldman; William Maixner
Journal:  Pain       Date:  2006-07-11       Impact factor: 6.961

Review 5.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

Review 6.  A case of pseudocholinesterase deficiency in the PACU.

Authors:  Camille Lynette Leadingham
Journal:  J Perianesth Nurs       Date:  2007-08       Impact factor: 1.084

7.  Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam.

Authors:  E D Kharasch; A Walker; N Isoherranen; C Hoffer; P Sheffels; K Thummel; D Whittington; D Ensign
Journal:  Clin Pharmacol Ther       Date:  2007-06-06       Impact factor: 6.875

8.  Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.

Authors:  Ulrike M Stamer; Frank Stüber; Thomas Muders; Frank Musshoff
Journal:  Anesth Analg       Date:  2008-09       Impact factor: 5.108

Review 9.  The impact of genetic factors on response to anaesthetics.

Authors:  A Mikstacki; M Skrzypczak-Zielinska; B Tamowicz; O Zakerska-Banaszak; M Szalata; R Slomski
Journal:  Adv Med Sci       Date:  2013       Impact factor: 3.287

10.  Clinical application of pharmacogenetics in pain management.

Authors:  D Max Smith; Kristin W Weitzel; Larisa H Cavallari; Amanda R Elsey; Siegfried Of Schmidt
Journal:  Per Med       Date:  2018-01-31       Impact factor: 2.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.